This Division is about price reductions for listed brands of pharmaceutical items.

(a)   other existing brands of the pharmaceutical item; and

(b)   existing brands of pharmaceutical items that have the same drug and manner of administration; and

(c)   existing brands of pharmaceutical items that have a drug in the same therapeutic group and the same manner of administration.

(a)   are triggered when Subdivision B applies to require a 16% price reduction to a new brand of a pharmaceutical item; or

(b)   are triggered when Subdivision CA applies to a new brand of a pharmaceutical item that has the same drug as an existing brand of a pharmaceutical item that is subject to an outstanding staged reduction; or

(c)   arise if the pharmaceutical item has a drug on F2 on a particular day.